Investment trusts with a US focus or those with holdings in resource companies and US banks performed well in November following Donald Trump's win to become the 45th President of the United States.
As expected, immediately after President-Elect Trump's (pictured) victory, biotech and healthcare investment trusts saw a significant turnaround in performance after months of volatility. As the threat...
Kaynor assumes role
Latest news and analysis
Moves to overweight equities and fixed income
Industry Voice Sponsored by T.Rowe Price: With market volatility likely to persist and the US dollar potentially near a peak, prudent investors may want to position their portfolios to take advantage of assets that have historically performed well late...
The Big Interview: Focus on ethical investment